Literature DB >> 20670910

Potency against enterotoxemia of a recombinant Clostridium perfringens type D epsilon toxoid in ruminants.

Francisco C F Lobato1, Catarina G R D Lima, Ronnie A Assis, Prhiscylla S Pires, Rodrigo O S Silva, Felipe M Salvarani, Anderson O Carmo, Christiane Contigli, Evanguedes Kalapothakis.   

Abstract

Enterotoxemia, a disease that affects domestic ruminants, is caused mainly by the epsilon toxin from Clostridium perfringens type D. Its eradication is virtually impossible, control and prophylaxis are based on systematic vaccination of herds with epsilon toxoids that are efficient in inducing protective antibody production. The use of recombinant toxins is one of the most promising of these strategies. This work evaluates the potency of a Cl. perfringens type D epsilon toxoid expressed by Escherichia coli administered to goats, sheep, and cattle. The etx gene was cloned into the pET-11a plasmid of E. coli strain BL21 to produce the recombinant toxin. Rabbits (n=8), goats, sheep, and cattle (n=5 for each species) were immunized with 0.2mg of the insoluble recombinant protein fraction to evaluate vaccine potency of the epsilon toxoid studied. Antibody titers were 40, 14.3, 26, and 13.1 IU/mL in the rabbit, goat, sheep, and cattle serum pools, respectively. The epsilon toxoid produced and tested in this work is adequate for immunization of ruminants against enterotoxemia. (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20670910     DOI: 10.1016/j.vaccine.2010.07.046

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  16 in total

1.  A low-toxic site-directed mutant of Clostridium perfringens ε-toxin as a potential candidate vaccine against enterotoxemia.

Authors:  Qing Li; Wenwen Xin; Shan Gao; Lin Kang; Jinglin Wang
Journal:  Hum Vaccin Immunother       Date:  2013-07-08       Impact factor: 3.452

Review 2.  Recombinant Alpha, Beta, and Epsilon Toxins of Clostridium perfringens: Production Strategies and Applications as Veterinary Vaccines.

Authors:  Marcos Roberto A Ferreira; Gustavo Marçal S G Moreira; Carlos Eduardo P da Cunha; Marcelo Mendonça; Felipe M Salvarani; Ângela N Moreira; Fabricio R Conceição
Journal:  Toxins (Basel)       Date:  2016-11-21       Impact factor: 4.546

3.  Cloning and expression of Clostridium perfringens type D vaccine strain epsilon toxin gene in E. coli as a recombinant vaccine candidate.

Authors:  Parastoo Aziminia; Reza Pilehchian-Langroudi; Kasra Esmaeilnia
Journal:  Iran J Microbiol       Date:  2016-08

Review 4.  Vaccines as alternatives to antibiotics for food producing animals. Part 2: new approaches and potential solutions.

Authors:  Karin Hoelzer; Lisa Bielke; Damer P Blake; Eric Cox; Simon M Cutting; Bert Devriendt; Elisabeth Erlacher-Vindel; Evy Goossens; Kemal Karaca; Stephane Lemiere; Martin Metzner; Margot Raicek; Miquel Collell Suriñach; Nora M Wong; Cyril Gay; Filip Van Immerseel
Journal:  Vet Res       Date:  2018-07-31       Impact factor: 3.683

5.  Evaluation of plant-produced <i>Clostridium perfringens</i> type D <i>epsilon</i> toxoid in a vaccine against enterotoxaemia in sheep.

Authors:  Tinyiko Mokoena; Ereck Chakauya; Michael Crampton; Boet Weyers; Malefa Tselanyane; Tsepo Tsekoa; Rachel Chikwamba
Journal:  Onderstepoort J Vet Res       Date:  2017-04-25       Impact factor: 1.792

Review 6.  Clostridium perfringens epsilon toxin: a malevolent molecule for animals and man?

Authors:  Bradley G Stiles; Gillian Barth; Holger Barth; Michel R Popoff
Journal:  Toxins (Basel)       Date:  2013-11-12       Impact factor: 4.546

7.  Clostridium perfringens epsilon toxin mutant Y30A-Y196A as a recombinant vaccine candidate against enterotoxemia.

Authors:  Monika Bokori-Brown; Charlotte A Hall; Charlotte Vance; Sérgio P Fernandes da Costa; Christos G Savva; Claire E Naylor; Ambrose R Cole; Ajit K Basak; David S Moss; Richard W Titball
Journal:  Vaccine       Date:  2014-04-05       Impact factor: 3.641

8.  Immunogenicity of a Trivalent Recombinant Vaccine Against Clostridium perfringens Alpha, Beta, and Epsilon Toxins in Farm Ruminants.

Authors:  Gustavo Marçal Schmidt Garcia Moreira; Felipe Masiero Salvarani; Carlos Eduardo Pouey da Cunha; Marcelo Mendonça; Ângela Nunes Moreira; Luciana Aramuni Gonçalves; Prhiscylla Sadanã Pires; Francisco Carlos Faria Lobato; Fabricio Rochedo Conceição
Journal:  Sci Rep       Date:  2016-03-23       Impact factor: 4.379

9.  Immunization with a novel Clostridium perfringens epsilon toxin mutant rETX(Y196E)-C confers strong protection in mice.

Authors:  Wenwu Yao; Jingjing Kang; Lin Kang; Shan Gao; Hao Yang; Bin Ji; Ping Li; Jing Liu; Wenwen Xin; Jinglin Wang
Journal:  Sci Rep       Date:  2016-04-06       Impact factor: 4.379

10.  Toxin-neutralizing antibodies protect against Clostridium perfringens-induced necrosis in an intestinal loop model for bovine necrohemorrhagic enteritis.

Authors:  Evy Goossens; Stefanie Verherstraeten; Bonnie R Valgaeren; Bart Pardon; Leen Timbermont; Stijn Schauvliege; Diego Rodrigo-Mocholí; Freddy Haesebrouck; Richard Ducatelle; Piet R Deprez; Filip Van Immerseel
Journal:  BMC Vet Res       Date:  2016-06-13       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.